Call Us : 1.224.938.9523 meetings@worldeventsforum.com
The Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center and 1Florida ADRC present
  • 18th Annual Mild Cognitive Impairment Symposium
  • Special Topic Workshop
  • Alzheimer's Public Educational Forum

January 18-19, 2020 | Miami, Florida, USA

AGENDA

2020 Preliminary Program

All sessions will be held at the Kovens Conference Center at the Florida International University.

18th Annual Mild Cognitive Impairment (MCI) Symposium 

Application of NIA-AA Research Framework

Saturday, JANUARY 18, 2020 ♦ 8:15 am – 5:25 pm

Review Symposium Objectives Here

7:15 am – 8:15Check-in and Continental Breakfast
8:00 – 8:15Welcome Notes/Introduction to SymposiumRanjan Duara, MD, FAAN
Mount Sinai Medical Center
8:15 – 11:25SESSION 1: Application of NIA-AA Research Framework in the Real World
Chair: Reisa Sperling, MD, Harvard Medical School
8:15 – 8:50KEYNOTE LECTURE: The Utility of the NIA-AA ATN Research Framework for Diagnosis and Staging of Alzheimer’s DiseaseRonald Petersen, MD, PhD
Mayo Clinic
8:50 – 9:10The ATN Framework: Prediction of Progression from MCI to Dementia?Leslie Shaw, PhD
Perelman School of Medicine
9:10 – 9:30The ATN Framework: Prediction of Progression from Normal Cognition to MCIReisa Sperling, MD
Harvard Medical School
9:30 – 9:50The ATN Framework: The Importance of Lifestyle Factors in Predicting Progression Jennifer Rabin, PhD
Sunnybrook Research Institute
9:50 – 10:10 The ATN Framework: Should Cognitive Reserve be Considered?David Bennett, MD
Rush University
10:10 – 10:35BREAK
10:35 – 10:55Application of the ATN Framework in African Americans and Caucasians Tammie Benzinger, MD
Washington University
10:55 – 11:25Panel Discussion/Q&AModerator: Julie Schneider, MD
Rush University
11:25am – 2:30 pm
SESSION 2: Application of Technology for Early Diagnosis and Assessment of MCI
Chair: Demetrius Maraganore, MD, University of Florida
11:25 – 11:30Session OverviewChair
11:30 – 12:05KEYNOTE LECTURE: Assessment of the Aging Brain using Computing Technology Jeffrey Kaye, MD
Oregon Health & Science University
12:05 – 1:00LUNCH
1:00 – 1:20Utility of Wearable Sensors and Computer Technology for the Assessment and Management of Neurodegenerative DiseasesDemetrius Maraganore, MD
University of Florida
1:20 – 1:40Use of Technology for the Direct Assessment of Every Day Functional AbilitiesSara Czaja, PhD
Weill Cornell Medicine
1:40 – 2:00Case StudiesRachel Nosheny, PhD
University California San Francisco
2:00 – 2:30Panel Discussion/ Q&AModerator: Alan Evans, PhD
McGill University
2:30 – 5:25SESSION 3: Synucleinopathies and MCI- Biology, Diagnosis, Progression and Treatment
Chair: James Galvin, MD, Florida Atlantic University
2:30 – 2:35OverviewCHAIR
2:35 – 3:10KEYNOTE LECTURE: The Role of Alpha-synuclein Aggregates in the Pathogenesis of Lewy Body and Parkinson’s Disease Maria Spillantini, PhD
University of Cambridge
3:10 – 3:35BREAK
3:35 – 3:55Screening and Clinical Diagnosis of Lewy Body DiseaseJames Galvin, MD
Florida Atlantic University
3:55 – 4:15Biomarkers for LBDDavid Irwin, MD
University of Pennsylvania
4:15 – 4:35Management of the Complex Behavioral Symptoms of LBD – Shared Decision Making Melissa Armstrong, MD
University of Florida
4:35 – 4:55Clinical Trials: PD and LBDCharbel Moussa, MBBS, PhD
Georgetown University
4:55 – 5:25Panel Discussion/ Q&ANickolas McFarland, MD, PhD
University of Florida
5:25 – 7:30Networking Reception

Special Topic Workshop: 

MCI and Dementia: From Epidemiology to Pathology

Sunday, JANUARY 19, 2020  ♦  8:30 am – 1:00 pm

Review Workshop Objectives Here

7:30 am – 8:30Continental Breakfast and Check-in
8:30 – 8:35IntroductionRanjan Duara, MD, FAAN
Mount Sinai Medical Center
8:35 – 8:40Workshop OverviewCHAIR: Zoe Arvanitakis, MD
Rush University
8:40 – 9:15KEYNOTE LECTURE: What Drives Disease Progression – Lessons from Pathology Sudha Seshadri, MD
Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases
9:15 – 9:40Risk Factors and Progression Rates of MCIMary Ganguli, MD, MPH
University of Pittsburgh
9:40 – 10:05Cognitive Predictors of disease Progression in Normal and MCI states – Impact of Amyloid Status and Positive Family HistoryRosie Curiel, PhD
University of Miami
10:05 – 10:35BREAK
10:35 – 11:00Female Sex and the Pathology of MCI and DementiaZoe Arvanitakis, MD
Rush University
11:00 – 11:25Pathological Subtypes of AD—Association to Sex, Age, Ethnicity and Genetics and Progression RatesMelissa Murray, PhD
Mayo Clinic
11:25 – 11:50TDP43 Pathology - Effect of Demographic FactorsGregory Jicha, MD, PhD
University of Kentucky
11:50 – 12:20 pmPanel Discussion/Q&AModerator: Steven DeKosky, MD
University of Florida
12:20 – 1:00LUNCH

Alzheimer’s Public Educational Forum: 

Mild Cognitive Impairment: How We Detect It, What Causes It, How We Can Prevent It

Sunday, JANUARY 19, 2020  ♦  1:30 pm – 5:00 pm

Review Forum Objectives Here

1:00 - 1:30pmCheck-in and Refreshments
1:30 – 1:35Welcome NotesRanjan Duara, MD, FAAN
Mount Sinai Medical Center
1:35 – 5:00 EDUCATIONAL FORUM:
Mild Cognitive Impairment: How We Detect It, What Causes it, How We Can Prevent It
CHAIR: Sudha Seshadri, MD
Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases
1:35 – 1:40OverviewCHAIR
1:40 – 2:15KEYNOTE LECTURE:
How Your Lifestyle Can Protect Your Brain
Jennifer Rabin, PhD
Sunnybrook Research Institute
2:15 – 2:40Who Gets MCI and What Happens to Them?Mary Ganguli, MD, MPH
University of Pittsburgh
2:40 – 3:05Web-based Technology to Screen and Monitor Cognitive HealthRachel Nosheny, PhD
University California San Francisco
3:05 – 3:30Everything You Wanted to Know About LBD but Were Afraid to AskJames Galvin, MD, MPH
Florida Atlantic University
3:30 – 3:55BREAK
3:55 – 4:20
Inside the Brain in MCI Zoe Arvanitakis, MD
Rush University
4:20 – 4:45Why You Should Donate Your Brain for ResearchTBA
4:45 – 5:15Panel Discussion and Q&A
5:15 – 5:30Closing NotesRanjan Duara, MD, FAAN
Mount Sinai Medical Center

Addressing Grievances about the MCI Symposium, the Special Topic Workshop or the Public Education Forum

Written evaluations are summarized and communicated to the activity’s Program Director and the faculty of the activity. Grievances shared directly at the conference are handled by the program staff or, if the grievance involves content, by the Program Director. Issues raised are shared with the faculty of the activity and considered when planning future activities.